To order this report: Cardiomyopathy Global Clinical Trials
Review, H2, 2014 http://www.
in E7 Countries by Trial Status 19 Clinical Trials
by Phase 20 In Progress Trials by Phase 21 Clinical Trials
by Trial Status 22 Clinical Trials
by End Point Status 23 Unaccomplished Trials of Vascular Dementias 24 Subjects Recruited Over a Period of Time 25 Clinical Trials
by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Vascular Dementias Therapeutics Clinical Trials
28 Prominent Drugs 29 Clinical Trial Profiles 30 Clinical Trial Overview of Top Companies 30 Pfizer Inc.
The DCRI has conducted more than 100 clinical trials
, enrolling 300,000 patients at 3,120 sites in 60 countries.
ZADAXIN is the only non-interferon based new drug that we know of currently in phase 3 HCV clinical trials
in the U.
Management presented an update on the current status of the Phenserine clinical trials
with shareholders and noted the following:
ImClone Systems and Bristol-Myers Squibb have also submitted to the FDA two protocols for large, randomized Phase III clinical trials
of ERBITUX in colorectal cancer.
Emissary has been conducting rigorous, detail-focused clinical trials
for medical device, pharmaceutical and biotechnology companies since 1995.
Data from more than 95% of the thousands of clinical trials
conducted annually are captured using a pen-and-paper approach, which often results in mistakes.
Immedient Business Solutions from INS, a Microsoft Gold Partner and leader in pharmaceutical process solutions, and part of INS, a global systems integrator with expertise in IT infrastructure, software and business solutions, announces the Clinical Trials
Solution Suite in conjunction with the launch of the Microsoft Digital Pharma vision.
For the complete study or more information about cancer clinical trials
, visit http://www.
com has added a new market research report: Tremor Global Clinical Trials
Review, H2, 2014 https://www.
Coalition Launches Cancer Clinical Trials
Awareness Campaign in Newsweek; Testifies Before House Committee; and Presents Research System Changes to NCI Director